Simon E Skalicky1, Andrew J R White2, John R Grigg2, Frank Martin1, Jeremy Smith3, Michael Jones1, Craig Donaldson3, James E H Smith3, Maree Flaherty4, Robyn V Jamieson5. 1. Discipline of Ophthalmology, University of Sydney, New South Wales, Australia3Department of Ophthalmology, The Children's Hospital at Westmead, Sydney, New South Wales, Australia. 2. Discipline of Ophthalmology, University of Sydney, New South Wales, Australia2Eye and Developmental Genetics Research Group, Western Sydney Genetics Program, The Children's Hospital at Westmead, Sydney, New South Wales, Australia3Department of Ophthalmology, The Children's Hospital at Westmead, Sydney, New South Wales, Australia. 3. Department of Ophthalmology, The Children's Hospital at Westmead, Sydney, New South Wales, Australia. 4. Eye and Developmental Genetics Research Group, Western Sydney Genetics Program, The Children's Hospital at Westmead, Sydney, New South Wales, Australia3Department of Ophthalmology, The Children's Hospital at Westmead, Sydney, New South Wales, Australia. 5. Discipline of Ophthalmology, University of Sydney, New South Wales, Australia2Eye and Developmental Genetics Research Group, Western Sydney Genetics Program, The Children's Hospital at Westmead, Sydney, New South Wales, Australia4Children's Medical Research Institute, Westmead, Sydney, New South Wales, Australia5Discipline of Paediatrics and Child Health, University of Sydney, Sydney, New South Wales, Australia.
Abstract
IMPORTANCE: Microphthalmia, anophthalmia, and coloboma form an interrelated spectrum of congenital eye abnormalities. OBJECTIVE: To document the ocular and systemic findings and inheritance patterns in patients with microphthalmia, anophthalmia, and coloboma disease to gain insight into the underlying developmental etiologies. DESIGN, SETTING, AND PARTICIPANTS: This retrospective consecutive case series was conducted at a tertiary referral center. Included in the study were 141 patients with microphthalmia, anophthalmia, and coloboma disease without a recognized syndromic etiology who attended the Westmead Children's Hospital, Sydney, from 1981-2012. EXPOSURE: Cases were grouped on the basis of the presence or absence of an optic fissure closure defect (OFCD); those with OFCD were further subdivided into microphthalmic and nonmicrophthalmic cases. Anophthalmic cases were considered as a separate group. MAIN OUTCOMES AND MEASURES: Associated ocular and systemic abnormalities and inheritance patterns were assessed. RESULTS: Of 141 cases, 61 (43%) were microphthalmic non-OFCD (NOFCD), 34 (24%) microphthalmic OFCD, 32 (23%) nonmicrophthalmic coloboma (OFCD), 9 (6%) anophthalmic, and 5 (4%) were unclassified. Sixty-three (45%) had bilateral disease. Eighty-four patients (60%) had an associated ocular abnormality; of these, cataract (P < .001) and posterior segment anomalies (P < .001) were most common in the NOFCD group. Forty-eight (34%) had an associated systemic abnormality, most commonly neurological, musculoskeletal and facial, urological and genital, or cardiac. Neurological abnormalities were most common in the anophthalmic group (P = .003), while urological abnormalities were particularly seen in the OFCD groups (P = .009). Familial cases were identified in both the OFCD and NOFCD groups, with a likely autosomal dominant inheritance pattern in 9 of 10 families. CONCLUSIONS AND RELEVANCE: This series indicated that the OFCD/NOFCD distinction may be useful in guiding evaluation for ocular and systemic associations, as well as the direction and analysis of genetic investigation.
IMPORTANCE: Microphthalmia, anophthalmia, and coloboma form an interrelated spectrum of congenital eye abnormalities. OBJECTIVE: To document the ocular and systemic findings and inheritance patterns in patients with microphthalmia, anophthalmia, and coloboma disease to gain insight into the underlying developmental etiologies. DESIGN, SETTING, AND PARTICIPANTS: This retrospective consecutive case series was conducted at a tertiary referral center. Included in the study were 141 patients with microphthalmia, anophthalmia, and coloboma disease without a recognized syndromic etiology who attended the Westmead Children's Hospital, Sydney, from 1981-2012. EXPOSURE: Cases were grouped on the basis of the presence or absence of an optic fissure closure defect (OFCD); those with OFCD were further subdivided into microphthalmic and nonmicrophthalmic cases. Anophthalmic cases were considered as a separate group. MAIN OUTCOMES AND MEASURES: Associated ocular and systemic abnormalities and inheritance patterns were assessed. RESULTS: Of 141 cases, 61 (43%) were microphthalmic non-OFCD (NOFCD), 34 (24%) microphthalmic OFCD, 32 (23%) nonmicrophthalmic coloboma (OFCD), 9 (6%) anophthalmic, and 5 (4%) were unclassified. Sixty-three (45%) had bilateral disease. Eighty-four patients (60%) had an associated ocular abnormality; of these, cataract (P < .001) and posterior segment anomalies (P < .001) were most common in the NOFCD group. Forty-eight (34%) had an associated systemic abnormality, most commonly neurological, musculoskeletal and facial, urological and genital, or cardiac. Neurological abnormalities were most common in the anophthalmic group (P = .003), while urological abnormalities were particularly seen in the OFCD groups (P = .009). Familial cases were identified in both the OFCD and NOFCD groups, with a likely autosomal dominant inheritance pattern in 9 of 10 families. CONCLUSIONS AND RELEVANCE: This series indicated that the OFCD/NOFCD distinction may be useful in guiding evaluation for ocular and systemic associations, as well as the direction and analysis of genetic investigation.
Authors: Malena Daich Varela; Laryssa A Huryn; Robert B Hufnagel; Wadih M Zein; Delphine Blain; Brian P Brooks Journal: Ophthalmology Date: 2020-05-17 Impact factor: 12.079
Authors: Jingjing Li; Wei Yang; Yuejun Jessie Wang; Chen Ma; Cynthia J Curry; Daniel McGoldrick; Deborah A Nickerson; Jessica X Chong; Elizabeth E Blue; James C Mullikin; Jennita Reefhuis; Wendy N Nembhard; Paul A Romitti; Martha M Werler; Marilyn L Browne; Andrew F Olshan; Richard H Finnell; Marcia L Feldkamp; Faith Pangilinan; Lynn M Almli; Mike J Bamshad; Lawrence C Brody; Mary M Jenkins; Gary M Shaw Journal: Am J Med Genet A Date: 2022-06-18 Impact factor: 2.578
Authors: Sarah E Seese; Linda M Reis; Brett Deml; Christopher Griffith; Adi Reich; Robyn V Jamieson; Elena V Semina Journal: Hum Mutat Date: 2021-05-24 Impact factor: 4.878
Authors: Daniel Kelberman; Lily Islam; Jörn Lakowski; Chiara Bacchelli; Estelle Chanudet; Francesco Lescai; Aara Patel; Elia Stupka; Anja Buck; Stephan Wolf; Philip L Beales; Thomas S Jacques; Maria Bitner-Glindzicz; Alki Liasis; Ordan J Lehmann; Jürgen Kohlhase; Ken K Nischal; Jane C Sowden Journal: Hum Mol Genet Date: 2014-01-09 Impact factor: 6.150